Tradition Wealth Management’s Ligand Pharmaceuticals LGND Stock Holding History

Tradition Wealth Management’s Portfolio LGND Stock Details LGND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-48	Closed	-$3K	–	1185
2022 Q3	$3K	Hold	48	–	–	﹤0.01%	1151
2022 Q2	$3K	Hold	48	–	–	﹤0.01%	1047
2022 Q1	$3K	Hold	48	–	–	﹤0.01%	1112
2021 Q4	$5K	Hold	48	–	–	﹤0.01%	1055
2021 Q3	$4K	Hold	48	–	–	﹤0.01%	1080
2021 Q2	$4K	Buy	+48	New	+$3.99K	﹤0.01%	1103
2021 Q1	–	Sell	-48	Closed	-$3K	–	925
2020 Q4	$3K	Buy	+48	New	+$2.74K	﹤0.01%	901

Other funds holding LGND

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SDJVC

St. Denis J. Villere & Co New Orleans, Louisiana $907M AUM 10.61% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Tradition Wealth Management's LGND Position: Q4 2022 in Review

Tradition Wealth Management sold out of Ligand Pharmaceuticals (LGND) in Q4 2022, closing a stake of 48 shares — an estimated $3K sold.

Tradition Wealth Management first reported a position in LGND in Q4 2020 and held it in 7 quarters. The position peaked at $5K in Q4 2021. 198 funds tracked by Wall St. Rank hold LGND as of Q4 2022.

Tradition Wealth Management reported no remaining Ligand Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
Tradition Wealth Management sold 48 Ligand Pharmaceuticals shares in Q4 2022, an estimated $3K.
Tradition Wealth Management first reported a position in Ligand Pharmaceuticals in Q4 2020 and held it in 7 quarters.
Tradition Wealth Management's Ligand Pharmaceuticals position peaked at $5K in Q4 2021.
198 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q4 2022.

Based on Tradition Wealth Management's 13F filing for Q4 2022, filed 3 Feb 2023.